Visit the TerrAscend Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
TORONTO, Jan. 10, 2018 /CNW/ – TerrAscend Corp. (CSE: TER) (“TerrAscend” or the “Company”) is pleased to announce the appointment of TerrAscend’s co-founder and Chief Operating Officer, Dr. Michael Nashat, as the Company’s new President & Chief Executive Officer, effective January 22, 2018. Dr. Nashat succeeds TerrAscend’s co-founder, Basem Hanna, in this capacity. Mr. Hanna will step down from the position on January 22, 2018 and will remain on TerrAscend’s Board of Directors as a key advisor to the Company moving forward.
TerrAscend’s strategic growth will be enhanced by Michael’s appointment as the Company continues to develop its footprint in Canada and abroad. Michael’s strong pharmaceutical experience and healthcare knowledge will be invaluable to TerrAscend’s continued growth.
Jason Wild, TerrAscend’s Chairman of the Board
Basem has skillfully led TerrAscend through many critical milestones over the past three years. We thank Basem for his dedication to TerrAscend and we look forward to his continued contribution to our Board of Directors.
In addition to his tenure at TerrAscend, Dr. Nashat is an accomplished executive in the pharmaceutical space. Dr. Nashat is the former Executive Director of the OnPharm Independent Pharmacy Group, which represents the commercial interests of over 340 pharmacies with annual sales of more than $300 million, in addition to being a former Board member with the Ontario College of Pharmacists, Canadian Foundation for Pharmacy, and Canadian Association of Chain Drug Stores. Dr. Nashat is also a former member of the Ontario Ministry of Health and Long Term Care’s Pharmacy Council, and currently serves as the Co-chair of the Ontario Pharmacists Association’s Owners Advisory Council.
Dr. Nashat has a Pharm.D. from the Albany College of Pharmacy and Health Science and completed his Post-Doctoral Fellowship in Neuroscience Medical Strategy at Bristol Myers Squibb/Rutgers University in New Jersey, U.S.
TerrAscend is a Canadian cannabis company that strives to create and deliver quality products and services that meet the evolving needs of patients. The Company provides support to patients through its wholly-owned subsidiaries, Solace Health Inc. (“Solace Health”), a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations and Terra Health Network Inc. (“Terra Health”), a clinical support program and education platform led by health care professionals.
Please visit www.TerrAscend.com for more information about the Company.
The most reliable, fact-based information on TerrAscend found only on its Investor Dashboard.
Before this cannabis stock news is here, it's published to subscribers on 420 Investor.